Form 8-K - Current report:
SEC Accession No. 0001213900-25-028003
Filing Date
2025-04-02
Accepted
2025-04-02 16:05:37
Documents
18
Period of Report
2025-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURENT REPORT ea0236661-8k_citius.htm   iXBRL 8-K 35285
2 FORM OF PRE-FUNDED WARRANT ISSUED ON APRIL 2, 2025 ea023666101ex4-1_citius.htm EX-4.1 90264
3 FORM OF PLACEMENT AGENT WARRANT ISSUED ON APRIL 2, 2025 ea023666101ex4-2_citius.htm EX-4.2 95421
4 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea023666101ex5-1_citius.htm EX-5.1 11044
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 1, 2025, BY AND AMONG C ea023666101ex10-1_citius.htm EX-10.1 202533
6 PRESS RELEASE, DATED APRIL 1, 2025 ea023666101ex99-1_citius.htm EX-99.1 11610
  Complete submission text file 0001213900-25-028003.txt   732694

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ctxr-20250401.xsd EX-101.SCH 3026
8 XBRL LABEL FILE ctxr-20250401_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE ctxr-20250401_pre.xml EX-101.PRE 22366
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0236661-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 25804338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)